Deutsche Bank’s bluebird bio BLUE Stock Holding History

Deutsche Bank’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-9	Closed	-$11K	–	5181
2018 Q4	$11K	Hold	9	–	–	﹤0.01%	4846
2018 Q3	$17K	Hold	9	–	–	﹤0.01%	4965
2018 Q2	$18K	Hold	9	–	–	﹤0.01%	5039
2018 Q1	$19K	Hold	9	–	–	﹤0.01%	5004
2017 Q4	$20K	Buy	+9	New	+$18.3K	﹤0.01%	4668

Other funds holding BLUE

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deutsche Bank's BLUE Position: Q2 2025 in Review

Deutsche Bank sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 20,068 shares — an estimated $97.9K sold.

Deutsche Bank first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $86.9M in Q2 2015. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Deutsche Bank reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Deutsche Bank sold 20,068 bluebird bio shares in Q2 2025, an estimated $97.9K.
Deutsche Bank first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
Deutsche Bank's bluebird bio position peaked at $86.9M in Q2 2015.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.